Characterization of ferroportin disease and SLC40A1-related hemochromatosis - Results from the EASL non-HFE registry

The authors aimed to characterize pathogenic mutations in the SLC40A1 gene, which causes ferroportin disease (FD) and SLC40A1-related hemochromatosis (SLC40A1-HC), and to compare their clinical outcomes with those of HFE-related hemochromatosis (HFE-HC). Their findings reveal significant phenotypic variability among patients with SLC40A1 variants, with higher iron concentrations and a greater risk of fibrosis associated with elevated transferrin saturation in SLC40A1-HC patients. The study emphasizes the need for tailored clinical management for these conditions, as life expectancy appears unaffected by phlebotomy treatment.